P130 Treatment of intermediate and high risk myelodysplastic syndrome patients with azacitidine. The Hellenic experience
V. Pappa, S. Papageorgiou, P. Tsirigotis, J. Dervenoulas, K. Girkas, E. Papageorgiou, H. Poulakidas, E. Papadaki, A. Galanopoulos, E. Vervessou, P. Panayotidis, A. Zomas, A. Symeonidis, T. EconomopoulVolume:
33
Year:
2009
Language:
english
Pages:
1
DOI:
10.1016/s0145-2126(09)70211-5
File:
PDF, 55 KB
english, 2009